Could a CF drug help other lung disease patients? new study explores
NCT ID NCT05743946
First seen Feb 12, 2026 · Last updated May 12, 2026 · Updated 14 times
Summary
This study tested the drug Trikafta in 32 adults with non-cystic fibrosis bronchiectasis, a chronic lung condition. Participants took the medication for four weeks while researchers monitored lung function, symptoms, and weight. Some also gave skin or blood samples to see how their cells responded to the drug. The goal was to see if Trikafta could improve breathing and quality of life in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON CYSTIC FIBROSIS BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Emory Clinic
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.